glp 1 and sarcopenia Weighing the risk of GLP-1 treatment in older adults: Should we be concerned about sarcopenic obesity? Balancing weight and muscle loss

This guarantees that your peptide arrives fresh and ready for use

Discover the key differences between retatrutide and semaglutide to find out which is right for you

Many individuals have experienced satisfactory results from Aqualyx injections and have noticed a visible reduction in fat

While GLP-1 RAs offer promising therapeutic outcomes, clinicians must address potential challenges, including gastrointestinal side effects, contraindications (e.g., pregnancy, severe GI disorders), and risks associated with improper compounding practices (48)(540)

Naunyn-Schmiedeberg's Arch Pharmacol 398 , 26092625 (2025)

There was no evidence demonstrating other significant safety issue differences (e.g., serious AEs) between GLP-1RA plus SGLT2i combination therapy and either GLP-1RA or SGLT2i monotherapy [59]